AzTrials
AzTrials

Parasitic DiseaseNCT04576273

Enterobius Vermicularis Infestation of the Appendix

An observational study of Parasitic Disease, run by Al-Azhar University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study identifies the incidence of appendiceal Enterobius vermicularis (E.v) infestation in all the patients undergoing appendectomy and evaluates the relationship between E.v infestation of the appendix and the acute appendicitis. Read more about this study

Who is it for?
Ages 4 to 90 years
Conditions the study is for
Parasitic Disease
What is being tested?
Pathology examination
How many people
1,150 participants
Where
1 siteSaudi Arabia
Study dates
1 Jun 2017to 31 May 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 90 years
  • All sexes
  • Child, Adult, Older adult

Study population: Saudi and non- Saudi patients suffering from acute appendicitis symptoms

Who may be able to join

  • All routine examined appendectomy specimens

Who cannot join

  • Cases with clinical suspicion of tumor Cases attached to the colectomy specimens

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • Abdulkarim Hasan

    Baljurashi

Other trials in Saudi Arabia

About this study

Official title: Enterobius Vermicularis in Appendectomy Specimens; Clinicopathological Assessment

This study identifies the incidence of appendiceal Enterobius vermicularis (E.v) infestation in all the patients undergoing appendectomy and evaluates the relationship between E.v infestation of the appendix and the acute appendicitis.

Read the detailed description

All the patients undergoing appendectomy surgical procedure for clinical picture of acute appendicitis in 3-years period at our referral hospital were evaluated to pick up the Enterobius vermicularis infestation of the appendix. These cases were evaluated for clinico-laboratory characterization to define the incidence in our country and the relationship between the E.v and initiation of the the inflammatory process to study the possibility of limitation of surgical intervention in acute abdomen conditions.

Being tested
Pathology examination
Medical subject headings
Parasitic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pathology examinationDiagnostic test

    Gross and microscopic evaluation

Study groups in NCT04576273
Study groupRoleWhat they receive
Non-parasiticNot described
Receives: Diagnostic Test: Pathology examination
ParasiticNot described
Receives: Diagnostic Test: Pathology examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association between acute inflammation and Enterobius vermicularis infestation

    All the studied Enterobius vermicularis cases will be evaluated microscopically to record the count of acute inflammatory cells per millimeter (mm) and per High Power Field (HPF) using the microscope scale measurement. This count will be compared with the inflamed appendectomy specimens without Enterobius infestation to assess the hypothesis of the association between the Enterobius infestation and the acute appendicitis. Also special stain (congo red) will be implicated in some indicated cases to detect eosinophils, eosinophils will be positively staines (orange color stain means positive) if the stain is faint that means negative and the cell is not eosinophil

    Measured: 3 years

  2. Incidence of Appendiceal Enterobius vermicularis

    An incidence of Enterobius infestation will be assessed by studying all the received specimens during a 3 years-period using formatting a master sheet and processing in Excel program

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2020
  2. Study start1 Jun 2017
  3. Primary completion31 May 2020
  4. Study completion31 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
1,150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04576273
Sponsor's protocol ID
3003
Status last verified
Sep 2020
First submitted
23 Sep 2020
Last updated
6 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Parasitic Disease, run by Al-Azhar University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association between acute inflammation and Enterobius vermicularis infestation (time frame: 3 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in